220 related articles for article (PubMed ID: 12688678)
1. Cytotoxicity and cell cycle effects of novel indolo[2,3-b]quinoline derivatives.
Humeniuk R; Kaczmarek L; Peczyńska-Czoch W; Marcinkowska E
Oncol Res; 2003; 13(5):269-77. PubMed ID: 12688678
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
Dassonneville L; Lansiaux A; Wattelet A; Wattez N; Mahieu C; Van Miert S; Pieters L; Bailly C
Eur J Pharmacol; 2000 Dec; 409(1):9-18. PubMed ID: 11099695
[TBL] [Abstract][Full Text] [Related]
3. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity and cell cycle analysis of quinoline alkaloids isolated from Haplophyllum canaliculatum Boiss.
Varamini P; Javidnia K; Soltani M; Mehdipour AR; Ghaderi A
Planta Med; 2009 Nov; 75(14):1509-16. PubMed ID: 19551611
[TBL] [Abstract][Full Text] [Related]
5. SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.
Badowska-Rosłonek K; Ciesielska A; Switalska M; Piskozub M; Peczyńska-Czoch W; Wietrzyk J; Kaczmarek Ł
Acta Pol Pharm; 2016; 73(3):683-92. PubMed ID: 27476287
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives.
Jonckers TH; van Miert S; Cimanga K; Bailly C; Colson P; De Pauw-Gillet MC; van den Heuvel H; Claeys M; Lemière F; Esmans EL; Rozenski J; Quirijnen L; Maes L; Dommisse R; Lemière GL; Vlietinck A; Pieters L
J Med Chem; 2002 Aug; 45(16):3497-508. PubMed ID: 12139461
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.
Godlewska J; Luniewski W; Zagrodzki B; Kaczmarek L; Bielawska-Pohl A; Dus D; Wietrzyk J; Opolski A; Siwko M; Jaromin A; Jakubiak A; Kozubek A; Peczyñska-Czoch W
Anticancer Res; 2005; 25(4):2857-68. PubMed ID: 16080538
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cells.
Lansiaux A; Laine W; Baldeyrou B; Mahieu C; Wattez N; Vezin H; Martinez FJ; Piñeyro A; Bailly C
Chem Res Toxicol; 2001 Jan; 14(1):16-24. PubMed ID: 11170504
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
[TBL] [Abstract][Full Text] [Related]
11. In Vitro and In Vivo Antitumor Activity of Indolo[2,3-
Altwaijry N; El-Ghlban S; El Sayed IE; El-Bahnsawye M; Bayomi AI; Samaka RM; Shaban E; Elmongy EI; El-Masry TA; Ahmed HMA; Attallah NGM
Molecules; 2021 Feb; 26(3):. PubMed ID: 33535575
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.
Lu CM; Chen YL; Chen HL; Chen CA; Lu PJ; Yang CN; Tzeng CC
Bioorg Med Chem; 2010 Mar; 18(5):1948-57. PubMed ID: 20171108
[TBL] [Abstract][Full Text] [Related]
14. DNA interaction and cytotoxicity of a new series of indolo[2,3-b]quinoxaline and pyridopyrazino[2,3-b]indole derivatives.
Arimondo PB; Baldeyrou B; Laine W; Bal C; Alphonse FA; Routier S; Coudert G; Mérour JY; Colson P; Houssier C; Bailly C
Chem Biol Interact; 2001 Oct; 138(1):59-75. PubMed ID: 11640915
[TBL] [Abstract][Full Text] [Related]
15. The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents.
Sidoryk K; Świtalska M; Jaromin A; Cmoch P; Bujak I; Kaczmarska M; Wietrzyk J; Dominguez EG; Żarnowski R; Andes DR; Bańkowski K; Cybulski M; Kaczmarek Ł
Eur J Med Chem; 2015 Nov; 105():208-19. PubMed ID: 26496013
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 6-substituted 6H-indolo[2,3-b]quinolines as novel cytotoxic agents and topoisomerase II inhibitors.
Kaczmarek L; Luniewski W; Zagrodzki B; Godlewska J; Osiadacz J; Wietrzyk J; Opolski A; Peczyńska-Czoch W
Acta Pol Pharm; 2002; 59(3):199-207. PubMed ID: 12230247
[TBL] [Abstract][Full Text] [Related]
17. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
18. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
[TBL] [Abstract][Full Text] [Related]
19. Membrane perturbations induced by new analogs of neocryptolepine.
Jaromin A; Korycińska M; Piętka-Ottlik M; Musiał W; Peczyńska-Czoch W; Kaczmarek Ł; Kozubek A
Biol Pharm Bull; 2012; 35(9):1432-9. PubMed ID: 22975492
[TBL] [Abstract][Full Text] [Related]
20. Neocryptolepine: A Promising Indoloisoquinoline Alkaloid with Interesting Biological Activity. Evaluation of the Drug and its Most Relevant Analogs.
Larghi EL; Bracca AB; Arroyo Aguilar AA; Heredia DA; Pergomet JL; Simonetti SO; Kaufman TS
Curr Top Med Chem; 2015; 15(17):1683-707. PubMed ID: 25915612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
